Navigation Links
HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council
Date:10/4/2010

BRANFORD, Conn., Oct. 4 /PRNewswire/ -- HistoRx was recognized as a 2010 Company to Watch by the Connecticut Technology Council at the Innovation Pipeline Awards ceremony last week in New Haven, Connecticut.  HistoRx was recognized for significant milestones achieved in 2010:

  • launching its proprietary AQUA® technology software on a second hardware platform -- the ScanScope FL from Aperio
  • signing a licensing deal with a national oncology reference lab for AQUA technology and several diagnostic assays based on it -- Genoptix Medical Laboratory (Nasdaq: GXDX)
  • receiving a U.S. patent for an application of AQUA technology to personalized medicine -- methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers, specifically thymidylate synthase (TS)

These achievements represent key indicators of the company's maturation from a life science technology company to a diagnostics developer nearing first clinical use of its products.

The Innovation & Entrepreneurship Summit is a juried event designed to showcase the products and services from approximately 100 exciting early stage companies in various advanced technology categories.  Each year the event draws several hundred investors, corporate business development executives, prospective customers and the media.  This multifaceted event included a technology showcase of the award-winning Companies to Watch, and focused on young, emerging technology companies with an innovative product or service and the potential to grow quickly.

The Connecticut Technology Council is a statewide association of technology oriented companies and institutions, providing leadership in areas of policy advocacy, community building and assistance for growing companies.  Speaking for over 2,000 companies that employ some 200,000 residents, the Connecticut Technology Council seeks to provide a strong and urgent voice in support of the creation of a culture of innovation.

HistoRx, Inc. is a leading developer of tissue-based theranostic solutions to advance individualized patient care.  The Company's products and services are based on proprietary AQUA® technology for tissue biomarker analysis.  AQUA® software is the only platform capable of precisely measuring protein biomarker concentration with sub-cellular resolution in tissue sections, enabling fully objective, standardized, reproducible, and automated analysis to guide targeted drug development and therapeutic decision making.  HistoRx currently helps biopharmaceutical companies advance their product pipelines by generating valuable new insights into the safety and effectiveness of targeted therapeutics in development for cancer and other diseases, and is developing clinical assays based on these insights.  The first clinical diagnostics based on AQUA® technology will be launched in late 2010.  For more information please visit:  www.historx.com.


'/>"/>
SOURCE HistoRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
3. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
4. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
5. Roche Scientist Recognized for Excellence in Peptide Chemistry
6. SEI Defined Benefit Client Recognized With Leading Plan Design Award
7. Nonin Medical Recognized for Influential Contributions in Medical Technology
8. China Sky One Medical, Inc.s AMI Diagnostic Kit Recognized as a National Innovation Project by NDRC
9. AQUA(R) Technology Recognized as Promising New Strategy for Hormone Receptor Testing in Breast Cancer by NCCN Task Force
10. Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
11. Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 18, 2017   Synthetic Biologics, Inc. ... therapeutics designed to preserve the microbiome to protect ... plans to initiate a Phase 2b/3 adaptive pivotal ... lovastatin lactone designed to reduce methane production by ... gut to treat the underlying cause of irritable ...
(Date:1/19/2017)... LONDON , Jan. 18, 2017 ... 2022 Summary GlobalData,s new report, "South Korea ... data on the South Korea Insulin Delivery market. The ... (in units) and average prices (USD) within market segments ... Insulin Pump Accessories. The report also provides company ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 ... titled, "Breast Imaging Technologies Market by Type: Global Opportunity Analysis ... technologies market size was valued at $2,544 million in 2015 ... at a CAGR of 8.4% from 2016 to 2022. ... together accounted for over three-fourths market share in 2015. ...
Breaking Medicine Technology:
(Date:1/19/2017)... (PRWEB) , ... January 18, 2017 , ... The CHP ... driving during a rain storm by slowing down and increasing the space between themselves ... 40. Los Angeles based car accident attorney Raymond R. Hassanlou notes that, rain or ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... text designs that will simplify the editing process for all media productions," said ... is a package of 30 simplistically styled self-animating paragraphs designed for multi-lined text ...
(Date:1/18/2017)... ... January 18, 2017 , ... A recent video posting ... global discussion about the benefits of fidgeting to relieve stress and anxiety. No ... Their Think Ink Pen had just completed a successful Kickstarter campaign raising $67,000 ...
(Date:1/18/2017)... USA; SAN JOSE, Calif, USA; and SHANGHAI, China – , ... ... (PRWEB) January 18, 2017 -- Global public health organization NSF ... arsenic V (pentavalent arsenic) to NSF/ANSI 53: Drinking Water Treatment ... water treatment units. This certification verifies that MicroCeramics’ NanoNose Pitcher ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Portee Insurance Agency, a ... business owners in central Maryland and the DC region, is inaugurating a charity event ... people nationally every year, making it the #1 killer in America. However, heart disease ...
Breaking Medicine News(10 mins):